Concepedia

Zhao Wei

ZW

Statistics

Publications

1

Citations

12

H-Index

1

Active since

2018

Affiliations

JT Pharmaceuticals (United States)(Current)

Zhao Wei is an author at JT Pharmaceuticals (United States) specializing in cancer immunology, programmed cell death ligand 1 inhibition, and immunotherapy.

Publications per year

2018–2018

1

Publications

1

Abstract A200: CBT-502 (TQB2450), a novel anti-PD-L1 antibody, demonstrates favorable activity in MC-38/H-11 murine colon and A375 human melanoma animal models

Zhao Wei, Ling Yang, Yingchun Li et al. · Molecular Cancer Therapeutics · 2018 · 12 citations

, , +17

1–1 of 1